Synthesis of Self-Amplifying Nucleic Acid Constructs 1232SA26Q0044
Summary
AI-generated · Dec 17, 2025Provide a service to generate five lipid nanoparticle-encapsulated self-amplifying nucleic acid constructs based on the genetic components of the alphavirus Venezuelan equine encephalitis virus (VEEV).
This is a combined synopsis/solicitation issued as a Request for Quotation; offers are requested and a separate written solicitation will not be issued. See Attachment 1 for solicitation terms, conditions, instructions, and evaluation criteria; provisions and clauses are incorporated by reference, and all responsible sources may submit a quotation for consideration.
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation; offers are being requested, and a separate written solicitation will not be issued. Solicitation number 1232SA25Q044 is issued as a Request for Quotation (RFQ) for a service to generate five lipid nanoparticle encapsulated self-amplifying nucleic acid based on the genetic components of the alphavirus Venezuelan equine encephalitis virus (VEEV). This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The applicable North American Industry Classification Standard Code is 541380. The small business size standard is $19.0M This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency. See Attachment 1 - Solicitation Terms and Conditions for applicable clauses, instructions, and evaluation criteria.
From Combined Synopsis/Solicitation posted on Dec 16, 2025This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12. This announcement constitutes the only solicitation; offers are being requested, and a separate written solicitation will not be issued. Solicitation number 1232SA25Q044 is issued as a Request for Quotation (RFQ) for a service to generate five lipid nanoparticle encapsulated self-amplifying nucleic acid based on the genetic components of the alphavirus Venezuelan equine encephalitis virus (VEEV). This acquisition is set-aside for small business concerns. This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at www.acquisition.gov. The applicable North American Industry Classification Standard Code is 541380. The small business size standard is $19.0M This acquisition is a Total Small Business Set-Aside. All responsible sources may submit a quotation which will be considered by the agency. See Attachment 1 - Solicitation Terms and Conditions for applicable clauses, instructions, and evaluation criteria.
From Combined Synopsis/Solicitation posted on Jan 29, 2026Notice history
3-
Combined Synopsis/Solicitation Posted Dec 16, 2025
-
Combined Synopsis/Solicitation Posted Jan 29, 2026View changes (1)
- Response Deadline: Jan 12, 2026 → Feb 06, 2026
-
Award Notice LATEST Posted Mar 05, 2026
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| VECTORBUILDER INC | CLRZY7CGLVM1 | 82GV2 | Chicago, IL |